Annual EBIT
$1.38B$83.00M+6.42%
Summary
- Current Value
- As of today, DGX annual EBIT is $1.38B, up +6.42% on
- Historical Performance
- DGX annual EBIT is down -49.98% over the past 3 years, and up +9.55% over the past 5 years
- All-Time High Comparison
- DGX annual EBIT is currently -49.98% below its historical high of $2.75B set on
- 3-Year Low Comparison
- DGX annual EBIT is +6.42% above its 3-year low of $1.29B reached on
- Sector Comparison
- DGX annual EBIT is higher than 95.51% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $1.38B | +6.4% | -50.0% | +9.6% | +0.1% | |
| Quarterly EBIT | $420.00M | +20.0% | +5.8% | -47.8% | +24.7% | |
| TTM EBIT | $1.59B | +17.5% | -15.5% | +0.8% | +17.0% | |
| Price | $174.44 | +13.3% | +14.1% | +41.9% | +228.3% | |
| PE Ratio | 20.47 | +2.3% | +6.0% | +73.5% | +56.0% | |
| Annual Revenue | $9.87B | +6.7% | -8.5% | +27.8% | +32.4% | |
| Annual EPS | $7.66 | +1.9% | -50.7% | +21.9% | +98.0% | |
| Annual EBITDA | $1.87B | +7.9% | -40.8% | +17.9% | +14.6% | |
| Annual Net Income | $916.00M | +1.3% | -55.8% | +3.7% | +19.7% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.38B | N/A | -0.5% |
| 5Y | $2.75B | -50.0% | |
| All | $2.75B | -50.0% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.29B | +6.4% | |
| 5Y | $1.29B | +6.4% | |
| All | -$601.28M | +328.8% |
EBIT History
FAQ
What is the current annual EBIT of DGX?
As of today, DGX annual EBIT is $1.38B
What is 1-year change in DGX annual EBIT?
DGX annual EBIT is up +6.42% year-over-year
What is 3-year change in DGX annual EBIT?
DGX annual EBIT is down -49.98% over the past 3 years
How far is DGX annual EBIT from its all-time high?
DGX annual EBIT is currently -49.98% below its historical high of $2.75B set on December 31, 2021
How does DGX annual EBIT rank versus sector peers?
DGX annual EBIT is higher than 95.51% of companies in Healthcare sector
When is DGX next annual earnings release?
The next annual earnings release for DGX is on
Quarterly EBIT
$420.00M$5.00M-1.18%
Summary
- Current Value
- As of today, DGX quarterly EBIT is $420.00M, down -1.18% on
- Historical Performance
- DGX quarterly EBIT is up +20.00% year-over-year, and up +5.79% over the past 3 years
- All-Time High Comparison
- DGX quarterly EBIT is currently -49.52% below its historical high of $832.00M set on
- 3-Year Low Comparison
- DGX quarterly EBIT is +44.33% above its 3-year low of $291.00M reached on an earlier date
- Sector Comparison
- DGX quarterly EBIT is higher than 95.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $420.00M | -1.2% | +20.0% | +5.8% | -47.8% | |
| Annual EBIT | $1.38B | – | +6.4% | -50.0% | +9.6% | |
| TTM EBIT | $1.59B | +4.6% | +17.5% | -15.5% | +0.8% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| PE Ratio | 20.47 | -3.9% | +2.3% | +6.0% | +73.5% | |
| Quarterly Revenue | $2.82B | +2.0% | +13.2% | +13.3% | +1.1% | |
| Quarterly EPS | $2.15 | -13.5% | +8.0% | -0.1% | -48.0% | |
| Quarterly EBITDA | $562.00M | -1.1% | +18.3% | +11.3% | -37.1% | |
| Quarterly Net Income | $257.00M | -12.9% | +8.9% | -6.2% | -56.4% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $425.00M | -1.2% | |
| 3Y | $425.00M | -1.2% | |
| 5Y | $832.00M | N/A | -49.5% |
| All | $832.00M | -49.5% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $367.00M | +14.4% | |
| 3Y | $291.00M | N/A | +44.3% |
| 5Y | $291.00M | +44.3% | |
| All | $9.10M | +4515.4% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of DGX?
As of today, DGX quarterly EBIT is $420.00M
What is DGX quarterly EBIT most recent change?
DGX quarterly EBIT was down -1.18% on September 30, 2025
What is 1-year change in DGX quarterly EBIT?
DGX quarterly EBIT is up +20.00% year-over-year
How far is DGX quarterly EBIT from its all-time high?
DGX quarterly EBIT is currently -49.52% below its historical high of $832.00M set on December 31, 2020
How does DGX quarterly EBIT rank versus sector peers?
DGX quarterly EBIT is higher than 95.98% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
TTM EBIT
$1.59B$70.00M+4.62%
Summary
- Current Value
- As of today, DGX TTM EBIT is $1.59B, up +4.62% on
- Historical Performance
- DGX TTM EBIT is up +17.48% year-over-year, and down -15.50% over the past 3 years
- All-Time High Comparison
- DGX TTM EBIT is currently -44.72% below its historical high of $2.87B set on
- 3-Year Low Comparison
- DGX TTM EBIT is +17.92% above its 3-year low of $1.35B reached on
- Sector Comparison
- DGX TTM EBIT is higher than 96.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $1.59B | +4.6% | +17.5% | -15.5% | +0.8% | |
| Annual EBIT | $1.38B | – | +6.4% | -50.0% | +9.6% | |
| Quarterly EBIT | $420.00M | -1.2% | +20.0% | +5.8% | -47.8% | |
| Price | $174.44 | -3.9% | +13.3% | +14.1% | +41.9% | |
| PE Ratio | 20.47 | -3.9% | +2.3% | +6.0% | +73.5% | |
| TTM Revenue | $10.85B | +3.1% | +13.7% | +5.4% | +29.8% | |
| TTM EPS | $8.52 | +1.9% | +14.4% | -16.0% | +5.6% | |
| TTM EBITDA | $2.15B | +4.2% | +18.1% | -6.9% | +11.9% | |
| TTM Net Income | $1.02B | +2.1% | +15.0% | -22.0% | -11.4% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.59B | at high | |
| 3Y | $1.62B | N/A | -2.2% |
| 5Y | $2.87B | -44.7% | |
| All | $2.87B | -44.7% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.41B | N/A | +12.2% |
| 3Y | $1.35B | +17.9% | |
| 5Y | $1.35B | +17.9% | |
| All | $18.80M | +8336.2% |
TTM EBIT History
FAQ
What is the current TTM EBIT of DGX?
As of today, DGX TTM EBIT is $1.59B
What is DGX TTM EBIT most recent change?
DGX TTM EBIT was up +4.62% on September 30, 2025
What is 1-year change in DGX TTM EBIT?
DGX TTM EBIT is up +17.48% year-over-year
How far is DGX TTM EBIT from its all-time high?
DGX TTM EBIT is currently -44.72% below its historical high of $2.87B set on June 30, 2021
How does DGX TTM EBIT rank versus sector peers?
DGX TTM EBIT is higher than 96.07% of companies in Healthcare sector
When is DGX next earnings release?
The next earnings release for DGX is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- DGX Official Website www.questdiagnostics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1022079/000102207925000218/0001022079-25-000218-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1022079/000102207925000044/0001022079-25-000044-index.htm
- DGX Profile on Yahoo Finance finance.yahoo.com/quote/DGX
- DGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dgx